AstraZeneca is making a major push into cell therapy with the acquisition of EsoBiotec, a company that has developed a ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...

AstraZeneca has agreed to purchase Belgium-based EsoBiotec for up to $1 billion. The acquisition is aimed at enhancing ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

Cooley and Covington & Burling have scored roles in AstraZeneca's $1bn acquisition of Belgian cancer treatment company ...

EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.

Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology.

The FTSE 100 company, which has a market capitalisation of £185.9 billion, confirmed the deal in an announcement to the London Stock Exchange on Monday. AstraZeneca was advised by a Covington team led ...

Alteogen Inc. signed its first billion-dollar partnership this year for ALT-B4 technology through two separate contracts with Astrazeneca plc’s U.K.- and U.S.-based Medimmune subsidiaries worth up to ...

British-Swedish pharmaceutical powerhouse AstraZeneca PLC has announced a landmark deal to acquire Belgian biotech firm EsoBiotec SA for up to $1 billion, marking a bold step into the future of cancer ...

E-commerce brand Shopify has acquired Vantage Discovery, a startup that builds AI-powered search technology for retailers ...

The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all ...